Filings
Finds words inside filing documents. Searching Cytek Biosciences, Inc.'s filings · 30 documents indexed.
14 documents · 103 matches
-
CTKB Cytek Biosciences, Inc. 10-Q 2026-11-04
Item 1A. Risk Factors
tariffs. These tariffs, and the related geopolitical uncertainty between the United States and China, may cause decreased demand for our products17 matches in this document -
CTKB Cytek Biosciences, Inc. 10-Q 2026-08-05
Item 1A. Risk Factors
tariffs. These tariffs, and the related geopolitical uncertainty between the United States and China, may cause decreased demand for our products17 matches in this document -
CTKB Cytek Biosciences, Inc. 10-Q 2026-05-07
Item 1A. Risk Factors
tariffs. These tariffs, and the related geopolitical uncertainty between the United States and China, may cause decreased demand for our products13 matches in this document -
CTKB Cytek Biosciences, Inc. 10-K 2026-02-26
Item 1A. Risk Factors
tariffs. These tariffs, and the related geopolitical uncertainty between the United States and China, may cause decreased demand for our products13 matches in this document -
CTKB Cytek Biosciences, Inc. 10-Q 2025-08-06
Item 1A. Risk Factors
tariffs. These tariffs, and the related geopolitical uncertainty between the United States and China, may cause decreased demand for our products11 matches in this document -
CTKB Cytek Biosciences, Inc. 10-Q 2025-05-08
Item 1A. Risk Factors
tariffs. These tariffs, and the related geopolitical uncertainty between the United States and China, may cause decreased demand for our products11 matches in this document -
CTKB Cytek Biosciences, Inc. 10-Q 2025-11-05
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
tariffs against U.S. goods and other non-tariff protectionist measures, such as procurement preferences or informal disincentives to engage with12 matches in this document -
CTKB Cytek Biosciences, Inc. 8-K 2026-11-04
tariffs and NIH funding policies on its business; Cytek’s ability to evaluate its prospects for future viability and predict1 match in this document -
CTKB Cytek Biosciences, Inc. 8-K 2026-08-05
impact of a one-time tariff refund, GAAP and adjusted gross margin in the second quarter of 2026 were 53% and 56%, respectively.2 matches in this document -
CTKB Cytek Biosciences, Inc. 8-K 2026-05-07
tariffs and NIH funding policies on its business; Cytek’s ability to evaluate its prospects for future viability and predict1 match in this document -
CTKB Cytek Biosciences, Inc. 8-K 2026-02-26
growth of 2% to 5% over full year 2025, assuming no change in current foreign currency exchange rates or 2025 US tariff policy.2 matches in this document -
CTKB Cytek Biosciences, Inc. 8-K 2026-01-13
tariffs and NIH funding policies on its business; Cytek’s ability to evaluate its prospects for future viability and predict1 match in this document -
CTKB Cytek Biosciences, Inc. 8-K 2025-11-05
tariffs and NIH funding policies on its business; Cytek’s ability to evaluate its prospects for future viability and predict1 match in this document -
CTKB Cytek Biosciences, Inc. 8-K 2025-08-06
tariffs and NIH funding policies on its business; Cyteks ability to evaluate its prospects for future viability and predict1 match in this document
Page 1 of 1 · 14 documents